These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10079062)

  • 41. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
    Bril V; Katzberg H; Donofrio P; Banach M; Dalakas MC; Deng C; Hanna K; Hartung HP; Hughes RA; Latov N; Merkies IS; van Doorn PA;
    Muscle Nerve; 2009 Apr; 39(4):448-55. PubMed ID: 19260050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous immune globulin for recurrent spontaneous abortion.
    Tecnologica MAP Suppl; 1998 May; ():11-3. PubMed ID: 10184996
    [No Abstract]   [Full Text] [Related]  

  • 43. Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.
    Wasserman RL; Ito D; Xiong Y; Ye X; Bonnet P; Li-McLeod J
    J Clin Immunol; 2017 Feb; 37(2):180-186. PubMed ID: 28160239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immune globulin for multiple sclerosis.
    Tecnologica; 1995 May; ():10. PubMed ID: 10168292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.
    Gaines AR
    Blood; 2000 Apr; 95(8):2523-9. PubMed ID: 10753830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
    Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
    Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura.
    Bussel JB; Hanna K;
    Am J Hematol; 2007 Mar; 82(3):192-8. PubMed ID: 17109385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacoeconomics of immunoglobulins in primary immunodeficiency.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):375-86. PubMed ID: 19670998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1.
    Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MW
    Pharmeuropa Bio; 2006 Nov; 2006(1):49-56. PubMed ID: 17270131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin.
    Haliasos E; Soder B; Rubenstein DS; Henderson W; Morrell DS
    Pediatr Dermatol; 2005; 22(6):530-5. PubMed ID: 16354255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).
    Ballow M; Berger M; Bonilla FA; Buckley RH; Cunningham-Rundles CH; Fireman P; Kaliner M; Ochs HD; Skoda-Smith S; Sweetser MT; Taki H; Lathia C
    Vox Sang; 2003 Apr; 84(3):202-10. PubMed ID: 12670369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immune system and intravenous administration of immune globulin. Part I, The immune system.
    Frey AM
    J Intraven Nurs; 1991; 14(5):315-30. PubMed ID: 1748915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune globulin intravenous products--notice to hospitals.
    Hogan V
    CMAJ; 1999 Apr; 160(7):1051-2, 1055-6. PubMed ID: 10207352
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
    Abdou NI; Greenwell CA; Mehta R; Narra M; Hester JD; Halsey JF
    Int Arch Allergy Immunol; 2009; 149(3):267-74. PubMed ID: 19218820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerability and safety of the intravenous immunoglobulin Octagam: a 10-year prospective observational study.
    Debes A; Bauer M; Kremer S
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1038-47. PubMed ID: 17636556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.